Navigation Links
Hospira Shares Results From Two Open-label Extension Studies for Biosimilar Infliximab in Patients With Rheumatoid Arthritis or Ankylosing Spondylitis
Date:10/31/2013

first monoclonal antibody (mAb) to be approved through the EMA biosimilars regulatory pathway. A biosimilar developed in line with EU requirements can be considered a therapeutic alternative to an existing biologic in Europe. Inflectra is not currently approved for use in the United States.

In the EU, Inflectra is indicated for:
Rheumatoid arthritis

Inflectra, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:

  • adult patients with active disease when the response to disease‑modifying antirheumatic drugs (DMARDs), including methotrexate, has been inadequate.
  • adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs.

In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X‑ray, has been demonstrated.

Adult Crohn's disease
Inflectra is indicated for:

  • treatment of moderately to severely active Crohn's disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.
  • treatment of fistulising, active Crohn's disease, in adult patients who have not responded despite a full and adequate course of therapy with conventional treatment (including antibiotics, drainage and immunosuppressive therapy).

Paediatric Crohn's disease
Inflectra is indicated for treatment of severe, active Crohn's disease in children and adolescents aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition thera
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Hospira Unveils New Quality Laboratory and Investments at Rocky Mount, N.C., Plant
2. Hospira Launches Q Core Sapphire Infusion System in the United States
3. Gastroenterologists Unlikely To Use Celltrion/Hospiras Infliximab Biosimilar Due To Lack Of Clinical Data In Inflammatory Bowel Disease
4. Hospira to Present at the Morgan Stanley Global Healthcare Conference
5. Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to Chemotherapy
6. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
7. Hospira dévoile sa stratégie appareil mondiale
8. Hospira enthüllt weltweite Gerätestrategie
9. Hospira revela estrategia global para sus dispositivos
10. Hospira revela estratégia global para dispositivos
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015   Precision Image Analysis ... designed to highlight advances in cardiovascular imaging and post-processing. ... of the Society for Cardiovascular Magnetic Resonance (SCMR) ... highlight improvements in patient management by providing broader access ... will help attendees to better understand appropriate use of ...
(Date:4/20/2015)... April 20, 2015  SillaJen, Inc., a private ... oncolytic immunotherapy products for cancer, today announced an ... Annual Meeting of the American Association for Cancer ... adapted version of its lead product candidate, Pexa-Vec ... an oncolytic immunotherapy designed to 1) rapidly de-bulk ...
(Date:4/20/2015)... April 20, 2015 The global ... segments the concerned global with analysis and forecast of ... and is estimated to reach $4,918.7 million by 2019, ... Browse through the TOC of global orthopedic ... of the industry trends and segments, with help of ...
Breaking Medicine Technology:Educational Webinar Teaches Improved Patient Management Through Broader Access to Cardiac MRI 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 2Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 3
... Feb. 24, 2011 /PRNewswire-Asia-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN; NYSE: ... completed the previously announced acquisition of BMP Sunstone Corporation ... today, BMP Sunstone stockholders approved the adoption of the ... Inc., a wholly owned subsidiary of sanofi-aventis, dated October ...
... BrainScope Company, Inc. today announced that Peter ... Medical Advisory Board.  He holds the distinguished title ... the University of Edinburgh, Scotland, United Kingdom.  This ... is entering the U.K. market with its "B-Ahead ...
Cached Medicine Technology:Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China 2BrainScope® Announces Appointment of Professor Peter Andrews, MD to Its Medical Advisory Board 2BrainScope® Announces Appointment of Professor Peter Andrews, MD to Its Medical Advisory Board 3BrainScope® Announces Appointment of Professor Peter Andrews, MD to Its Medical Advisory Board 4
(Date:4/21/2015)... 2015 eSight is the only technology in ... see and, on Tuesday, May 5th, Low Vision Specialists ... will host an unveiling and demonstration of the technology ... MD & VA will be the first ophthalmic practice in ... individual patient demonstrations will be available on the day of ...
(Date:4/21/2015)... Scranton, Pennsylvania (PRWEB) April 21, 2015 ... online Master of Science in Health Informatics to ... interpret medical data into a meaningful, comprehensive wellness ... informatics is critical to the development and implementation ... true for administrative, clinical, financial and managerial operations ...
(Date:4/21/2015)... Irvine, CA (PRWEB) April 21, 2015 ... will celebrate the grand opening of its Center ... Hospital and Hollywood Presbyterian Hospital. The campus recently ... is not the only thing that has administrators ... programs have expanded from the Master of Science ...
(Date:4/21/2015)... Renewable energy, sustainable living, the greening of ... Day topics USM Studios ’ programming covers in ... affect of climate change on the planet, the award-winning ... on the environmental concerns affecting the nation and world ... lifestyles, clean air options, and much more when the ...
(Date:4/21/2015)... MA (PRWEB) April 21, 2015 ... language pathologists, physical therapist assistants, occupational therapist assistants, ... strategies and techniques to help children across the ... available through Education Resources Inc. ... since 2008, this highly acclaimed yoga curriculum addresses ...
Breaking Medicine News(10 mins):Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:West Coast University Opens a Center for Graduate Studies 2Health News:West Coast University Opens a Center for Graduate Studies 3Health News:USM Studios’ Programming Focuses on the Environment 2Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2
... , , NEW YORK, ... that it is providing a grant of $200,000 to Abiant, Inc. ... for Alzheimer,s Disease. Abiant, a privately held company, is dedicated ... of neurologic and neuropsychiatric disorders. , , ...
... , CINCINNATI, Sept. 9 Leading ... that healthful aging depends on our current habits. "Our bodies, ... precautionary measures to strengthen ourselves," explains the women,s health expert and ... all areas that are often overlooked or taken for granted until ...
... HARBIN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ -- China Kangtai ... grower,developer, manufacturer and marketer of a variety of cactus-based ... Annual Global Investment,Conference to be held on September 9-11, ... as part of the Asia Track program on September ...
... , , , ... Policymakers to Adopt Obesity Recommendations , , SILVER ... other steering committee members of the Strategies to Overcome and Prevent (STOP) ... develop effective recommendations to urge policymakers to act on the inclusion of ...
... , , ... , the market leader in enterprise content compliance ... the availability of a new, Software-as-a-Service (SaaS) solution for managing ... Results solution (Virtx CTRR) is a robust offering that automates ...
... Bayer Diabetes Care today introduced two new vibrant colors of Bayer,s ... , The BREEZE2 new color meters will offer ... BREEZE2 meter, such as a 10-test disc that stores test strips ... individual strips every time they test their blood glucose. The 10-test ...
Cached Medicine News:Health News:Alzheimer's Drug Discovery Foundation Funds Abiant, Inc. to Develop a Positron Emission Tomography (PET) Imaging Diagnostic for Alzheimer's Disease 2Health News:Alzheimer's Drug Discovery Foundation Funds Abiant, Inc. to Develop a Positron Emission Tomography (PET) Imaging Diagnostic for Alzheimer's Disease 3Health News:Leading Women's Health Expert Offers Preventive Tips for Healthful Aging 2Health News:Leading Women's Health Expert Offers Preventive Tips for Healthful Aging 3Health News:Leading Women's Health Expert Offers Preventive Tips for Healthful Aging 4Health News:China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009 2Health News:China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009 3Health News:Obesity Driving America's Healthcare to a Tipping Point 2Health News:Obesity Driving America's Healthcare to a Tipping Point 3Health News:Obesity Driving America's Healthcare to a Tipping Point 4Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 2Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 3Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 4Health News:Bayer's BREEZE(R)2 Meter Available in Two New Vibrant Colors for a Limited Time 2
9 mm slightly curved blade. Hexagonal handle....
9 mm blade....
4 mm disposable bevel blade. Malleable shafts. Flat spot on handle designed to guide knife in perforation....
Storz Ear Knife Handle....
Medicine Products: